Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-18
2011-10-04
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S279000, C514S264110
Reexamination Certificate
active
08030317
ABSTRACT:
Compounds of the following formula are provided for use with MEK:wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
REFERENCES:
patent: 7378423 (2008-05-01), Kawasaki et al.
patent: 2004/0266777 (2004-12-01), Claus et al.
patent: 2005/0026970 (2005-02-01), Barrett et al.
patent: 2005/0222177 (2005-10-01), Sim et al.
patent: 2008/0125437 (2008-05-01), Dong et al.
patent: 2008/0146560 (2008-06-01), Hoelzemann et al.
patent: 2009/0124595 (2009-05-01), Dong et al.
patent: 2009/0246198 (2009-10-01), Dong et al.
patent: 1894932 (2008-03-01), None
patent: WO 93/20055 (1993-10-01), None
patent: WO 96/34867 (1996-11-01), None
patent: WO 00/42022 (2000-07-01), None
patent: WO 01/55147 (2001-08-01), None
patent: WO 02/06213 (2002-01-01), None
patent: WO 02/059083 (2002-08-01), None
patent: WO 02/094824 (2002-11-01), None
patent: WO 03/077855 (2003-09-01), None
patent: WO 2005/009975 (2005-02-01), None
patent: WO 2005/002351 (2005-03-01), None
patent: WO 2005/051300 (2005-06-01), None
patent: WO 2005/051302 (2005-06-01), None
patent: WO 2005/051906 (2005-06-01), None
patent: WO 2005/121142 (2005-12-01), None
patent: WO 2006/050800 (2006-05-01), None
patent: WO 2006/058752 (2006-06-01), None
patent: WO 2008/010964 (2008-01-01), None
patent: WO 2008/055842 (2008-05-01), None
patent: WO 03/077914 (2008-11-01), None
patent: WO2010/059503 (2010-05-01), None
Dong Qing
Kaldor Stephen W.
Brustein Mitchell R.
Jaisle Cecilia M
Stemerick David M.
Takeda Pharmaceutical Company Limited
Wilson James O
LandOfFree
MAPK/ERK kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with MAPK/ERK kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MAPK/ERK kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4271526